Carcinogenesis, Vol. 23, No. 1, 81-86,
January 2002
© 2002 Oxford University Press
CANCER BIOLOGY |
Metallothionein 2A expression is associated with cell proliferation in breast cancer
1 Anatomy Department,
2 Microbiology Department and
3 Biochemistry Department, National University of Singapore, 4 Medical Drive, S117 597, Singapore and
4 Pathology Department, Singapore General Hospital, Outram Road, S169 608, Singapore
Metallothioneins (MTs) belong to a family of cysteine-rich, metal-binding intracellular proteins, which have been linked with cell proliferation. In this study, expression levels of the 8 known MT-1 and MT-2 functional isoforms in human invasive ductal breast cancer specimens were determined by RT–PCR. The expression profiles of the MT protein and MT-2A mRNA were further evaluated in 79 cases of human invasive ductal breast carcinoma by immunohistochemistry and in situ hybridization, and correlated with cancer cell proliferation (determined by Ki-67 nuclear antigen immunolabeling). MT-1A, MT-1E, MT-1F, MT-1G, MT-1H, MT-1X and MT-2A but not MT-1B, were detected in breast cancer tissue samples. The MT-2A mRNA transcript was the highest among all the isoforms detected. A positive correlation was observed between MT-2A mRNA and MT protein expression with Ki-67 labeling (P = 0.0003 and P < 0.0001, respectively) but not with apoptosis (P = 0.1244 and P = 0.8189, respectively). Co-localization of the MT protein and Ki-67 nuclear antigen in breast cancer cells was demonstrated by double immunofluorescence staining. There was also significantly higher MT protein and MT-2A mRNA expression in histological grade 3 tumors than in histological grade 1 and 2 tumors. The finding that MT 2A appears to be the main isoform associated with cell proliferation in invasive ductal breast cancer tissues, may have therapeutic implications.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. J. Murphy, T. Kimura, B. G. Sato, Y. Shi, and G. K. Andrews Metallothionein Induction by Hypoxia Involves Cooperative Interactions between Metal-Responsive Transcription Factor-1 and Hypoxia-Inducible Transcription Factor-1{alpha} Mol. Cancer Res., March 1, 2008; 6(3): 483 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Scibetta, S. Santangelo, J. Coleman, D. Hall, T. Chaplin, J. Copier, S. Catchpole, J. Burchell, and J. Taylor-Papadimitriou Functional Analysis of the Transcription Repressor PLU-1/JARID1B Mol. Cell. Biol., October 15, 2007; 27(20): 7220 - 7235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-H. Bay, R. Jin, J. Huang, and P.-H. Tan Metallothionein as a prognostic biomarker in breast cancer. Experimental Biology and Medicine, October 1, 2006; 231(9): 1516 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Gurel, D. A. Sens, S. Somji, S. H. Garrett, T. Weiland, and M. A. Sens Post-Transcriptional Regulation of Metallothionein Isoform 1 and 2 Expression in the Human Breast and the MCF-10A Cell Line Toxicol. Sci., June 1, 2005; 85(2): 906 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Kim, H.-Y. Sohn, S. Y. Yoon, J.-H. Oh, J. O. Yang, J. H. Kim, K. S. Song, S.-M. Rho, H. S. Yoo, Y. S. Kim, et al. Identification of Gastric Cancer-Related Genes Using a cDNA Microarray Containing Novel Expressed Sequence Tags Expressed in Gastric Cancer Cells Clin. Cancer Res., January 15, 2005; 11(2): 473 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. G. Jeong, C.-K. Youn, H.-J. Cho, S.-H. Kim, M.-H. Kim, H.-B. Kim, I.-Y. Chang, Y.-S. Lee, M.-H. Chung, and H. J. You Metallothionein-III Prevents {gamma}-Ray-induced 8-Oxoguanine Accumulation in Normal and hOGG1-depleted Cells J. Biol. Chem., August 13, 2004; 279(33): 34138 - 34149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. A. HAROON, K. AMIN, P. LICHTLEN, B. SATO, N. T. HUYNH, Z. WANG, W. SCHAFFNER, and B. J. MURPHY Loss of metal transcription factor-1 suppresses tumor growth through enhanced matrix deposition FASEB J, August 1, 2004; 18(11): 1176 - 1184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-K. Tai, O. J.-K. Tan, V. T.-K. Chow, R. Jin, J. L. Jones, P.-H. Tan, A. Jayasurya, and B.-H. Bay Differential Expression of Metallothionein 1 and 2 Isoforms in Breast Cancer Lines with Different Invasive Potential: Identification of a Novel Nonsilent Metallothionein-1H Mutant Variant Am. J. Pathol., November 1, 2003; 163(5): 2009 - 2019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Lee, W. Woo, B. Wu, A. Kummer, H. Duminy, and Z. Xu Zinc Accumulation in N-Methyl-N-Nitrosourea-Induced Rat Mammary Tumors Is Accompanied by an Altered Expression of ZnT-1 and Metallothionein Experimental Biology and Medicine, June 1, 2003; 228(6): 689 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Shimoda, W. E. Achanzar, W. Qu, T. Nagamine, H. Takagi, M. Mori, and M. P. Waalkes Metallothionein Is a Potential Negative Regulator of Apoptosis Toxicol. Sci., June 1, 2003; 73(2): 294 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J M M Tan, E P C Tock, and V T K Chow The novel human MOST-1 (C8orf17) gene exhibits tissue specific expression, maps to chromosome 8q24.2, and is overexpressed/amplified in high grade cancers of the breast and prostate Mol. Pathol., April 1, 2003; 56(2): 109 - 115. [Abstract] [Full Text] [PDF]
|
|